glp-1 receptor agonist common side effects Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of Understanding the Risks and Side

2023;doi:10.1016/S0140-6736(23)01163-7

One of these catechins known as epigallocatechin-3-gallate (EGCG) is of particular interest in the context of ALS

& Ba, X

GEN enhances the expression of miR-145-5p, which inhibits the NF-B pathway and thus suppresses inflammatory responses and angiogenesis ( 3 Clinical impact of GLP-1RAs on the eye The promising mechanism of GLP-1RAs in the eye further facilitates clinical evidence

Newly formed Dglucuronides exhibit increased watersolubility and are easily eliminated from the body in urine or bile

MMP14 in sarcoma: a regulator of tumor microenvironment communication in connective tissues